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The RNA-dependent RNA polymerase (RdRp) of influenza A virus consists of three
subunits, PB2, PB1, and PA, and catalyses both viral RNA genome replication and
transcription. Cotransfection of four monocistronic expression vectors for these subunits
and nucleoprotein with an expression vector for viral RNA reconstitutes functional viral
ribonucleoprotein complex (vRNP). However, the specific activity of reconstituted RdRp
is usually very low since the expression level and the ratio of the three subunits by
transfection are uncontrollable at single-cell levels. For efficient reconstitution of RdRp
and vRNP, their levels need to be at least comparable. We constructed polycistronic
expression vectors in which the coding sequences of the three subunits were joined
with the 2A-like self-processing sequence of Thosea asigna virus (TaV2A) in various
orders. The level of PB1 protein, even when it was placed at the most downstream,
was comparable with that expressed from the monocistronic PB1 vector. In contrast,
the levels of PB2 and PA were very low, the latter of which was most likely due
to proteasomal degradation caused by the TaV2A-derived sequences attached to
the amino- and/or carboxyl-terminal ends in this expression system. Interestingly,
two of the constructs, in which the PB1 coding sequence was placed at the most
upstream, showed much higher reporter activity in a luciferase-based mini-genome
assay than that observed by cotransfection of the monocistronic vectors. When
the coding sequence of selective antibiotic marker was further placed at the most
downstream of the PB1-PA-PB2 open reading frame, stable cells expressing RdRp
were easily established, indicating that acquisition of antibiotic resistance assured the
expression of upstream RdRp. The addition of an affinity tag to the carboxyl-terminal
end of PB2 allowed us to isolate reconstituted vRNP. Taken together, the polycistronic
expression system for influenza virus RdRp may be available for functional and
structural studies on vRNP.
Keywords: self-processing sequence, polycistronic expression, RNA-dependent RNA polymerase,
ribonucleoprotein complex, proteasomal degradation
Frontiers in Microbiology | www.frontiersin.org 1 March 2016 | Volume 7 | Article 288
fmicb-07-00288 March 5, 2016 Time: 18:35 # 2
Momose and Morikawa Polycistronic Expression of Influenza Virus RdRp
INTRODUCTION
The genome of influenza A virus consists of eight-segmented
negative sense, single-strand RNAs (vRNAs) (Portela and Digard,
2002). Both termini of each vRNA form a partially double-
stranded structure so-called “panhandle” region, which functions
as the transcription promoter and the genome replication origin
(Desselberger et al., 1980; Hsu et al., 1987). Each vRNA segment
exists as a ribonucleoprotein complex (vRNP) in which viral
RNA-dependent RNA polymerase (RdRp) binds the panhandle
region, and nucleoproteins (NP) regularly bind the single strand
region. This vRNP structure is required for full-length RNA
synthesis (Beaton and Krug, 1986; Shapiro and Krug, 1988),
the localization of progeny vRNP on Rab11-positive recycling
endosome (Amorim et al., 2011; Eisfeld et al., 2011; Momose
et al., 2011), high-order assembly of vRNPs, leading to selective
packaging of eight progeny vRNP segments into a virion
(Hutchinson et al., 2010).
Influenza A virus RdRp is a heterotrimeric complex of
PB2, PB1, and PA subunits and is a multifunctional enzyme
(Fodor, 2013) that catalyzes both primer-dependent viral mRNA
transcription (Plotch et al., 1981; Robertson et al., 1981; Poon
et al., 1999; Guilligay et al., 2008; Dias et al., 2009) and primer-
independent genome RNA replication (Young and Content,
1971; Hay et al., 1982), the latter of which consists of two distinct
steps of RNA syntheses. The first step is the complementary
RNA (cRNA) synthesis and the second step is the synthesis of
vRNA from the cRNA template for the amplification of progeny
vRNP. Structural and functional studies indicate that the amino-
terminal (N-terminal) end of PB1, the active center subunit for
RNA synthesis, is inserted into the cavity of carboxyl-terminal
(C-terminal) domain of PA (He et al., 2008; Obayashi et al.,
2008), while the C-terminal domain of PB1 interacts with the
N-terminal domain of PB2 (Sugiyama et al., 2009). It has been
thought that intermolecular interactions of these subunits and
their interactions with host factors are involved in switching the
RdRp between transcriptase and replicase and in controlling the
2-step replication of vRNA.
In vitro viral RNA synthesis systems with purified RdRp/vRNP
(Kawakami and Ishihama, 1983; Honda et al., 1987) have been
used to study the function of the viral RdRp, including the
promoter structure (Parvin et al., 1989), cap-snatching (Plotch
et al., 1979), and host factors required for efficient RdRp activity
(Nagata et al., 1989). In vivo (cell-based) systems so-called mini-
gonome assays, in which a reporter gene is expressed from a
model viral genome by RdRp expressed in trans from plasmid
vectors or helper virus infection, can be also used to find
new RdRp-specific antivirals (Lutz et al., 2005; Ozawa et al.,
2013; Wang et al., 2015). For these purposes, stable cell lines
expressing viral RdRp have been attempted to be established
(Li et al., 1989; Kimura et al., 1992). However, current systems
still have limitations and drawbacks and make biochemical
analyses difficult to achieve.
One of the limitations is the instability of purified RdRp.
The vRNP purified from virions is relatively stable, but further
purification using micrococcal nuclease or cesium chloride
(Seong et al., 1992), by which NP and vRNA molecules are
dissociated, lowers the specific activity of the RdRp (activity
per mass). Sole expression of each RdRp subunit in Escherichia
coli cells is known to result in protein aggregation and
in vitro reconstitution of the active RdRp complex has not
been established. In transfection-based systems, although the
expression levels and the ratio of RdRp subunits in total cells can
be controlled by the DNA amounts used for transfection, they
varied in each cell. If one of the RdRp subunits does not express
well in a cell, the other subunits become dead-end products.
Indeed, previous reports indicated that serial affinity purifications
after reconstitution of vRNP were required to eliminate such
dead-end products (Mayer et al., 2007; Jorba et al., 2008). Multi-
subunit complexes such as influenza virus RdRp are needed to
be correctly assembled for their activity, and this is possible
only when all the subunits are equally expressed in individual
cells, such as stable cell lines expressing the three subunits.
However, it is time-consuming and complicated to select cell
clones expressing the three RdRp subunits by the RdRp activity-
based screening.
We aimed to efficiently reconstitute multi-subunit complexes
such as viral RdRp and vRNP complexes in culture cells. To
this end, we constructed a polycistronic expression vector in
which three coding sequences (CDSs) of RdRp subunits are
concatenated in-frame with the CDS of Thosea asigna virus 2A-
like self-processing sequence of the capsid precursor protein
(referred to as TaV2A) (Pringle et al., 1999; Donnelly et al.,
2001a), and reconstituted the active RdRp at single cell levels.
The 2A/2A-like peptides are approximately 20 amino acids
in length and are encoded in various virus genomes such
as picornaviruses (Luke et al., 2008). For this purpose, the
2A sequence of foot-and-mouth disease virus has been studied
in most detail (Ryan et al., 1991). The molecular mechanisms of
self-processing have been suggested as follows. The translation
of self-processing 2A sequence is terminated at the penultimate
glycyl residue and restarts at the last prolyl residue without
connecting these glycyl-prolyl residues by a peptide bond
(Donnelly et al., 2001b). Resultant upstream protein has 2A
sequence until the penultimate glycine at the C-terminal end and
downstream protein has an additional proline at the N-terminal
end after self-processing. In this report, we employ TaV2A-
dependent polycistronic expression systems and show efficient
reconstitution of functional (biologically active) influenza A
virus RdRp. We also discuss not only these advantages, but
also the drawbacks about self-processing 2A sequence-based
polycistronic expression systems.
MATERIALS AND METHODS
Virus Strain, Antibodies, and Cell Lines
Influenza virus A/Puerto Rico/8/34 (PR8) strain was used
throughout this work. Details of rabbit anti-PB2, PB1, and
PA antisera (Kawaguchi et al., 2005; Naito et al., 2007b),
and anti-NP polyclonal antibody raised against the full length
of PR8 NP (Momose et al., 2007) are described elsewhere.
A polyclonal antibody specific for the processed form of
TaV2A peptide (anti-TaV2Apep, Scrum, Japan) was isolated
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from rabbits immunized with a corresponding synthetic peptide,
cGSLLTaGDVEENPG, with modification of the N-terminal
cysteine and internal alanine (lower case c and a, respectively).
Human embryonic kidney (HEK293T) and Madin-Darby
canine kidney (MDCK) cells were maintained in Dulbecco’s
modified Eagle medium (Cat. D5796, Sigma–Aldrich, USA)
supplemented 10% fetal bovine serum at 37◦C under 5% CO2
conditions.
Construction of v/cRNA and
Recombinant Protein Expression Vectors
Construction of the PR8 vRNA expression vectors (pPolI-PR8-
x, x = segment number) were essentially described elsewhere
(Neumann et al., 1999). At hybridization sites of primers
for semiquantitative real-time PCR (qPCR) as shown in our
previous report (Momose et al., 2011), PCR-based synonymous
substitutions of pPolI-PR8-x were carried out using mutated
primer sets (Supplementary Table S1). Consequently, neither
the modified vectors (pPolI-modPR8-x) nor its transcripts are
detectable by using the original qPCR primers. For the standard
DNA of the modified segment-specific qPCR, the plasmid
(pBSmodPR8qPCRSTD) which contains one copy each of eight
amplicons was constructed as previously reported (Momose et al.,
2011). For cRNA expression, the cDNA for each cRNA was made
using conversion primers (Supplementary Table S2, P37–P39)
and was cloned into pHH21 (Neumann et al., 1999) (referred to
as pPolI-modPR8-Cx) by the In-Fusion cloning system (Clontech
Laboratories, USA). As a reporter cRNA expression vector, we
used the reverse construct of phPolI-vNS-Luc (Murano et al.,
2014) (referred to as phPolI-cNS-Luc) in which the NS1/2 CDSs
of the eighth/NS segment cRNA expression vector was replaced
with the firefly luciferase CDS.
The CDSs of PB2, PB1, PA, and NP were amplified from
pPolI-modPR8-1, -2, -3, and -5, respectively, using specific
primer sets (Supplementary Table S2). The hygromycin B
phosphotransferase (HygR) and Aequorea coerulescens GFP
(AcGFP) CDSs were derived from pEBMulti-Hyg vector (Wako
Pure Chemicals, Japan) and pAcGFP1-Tubulin vector (Clontech
Laboratories), respectively. These CDSs were subcloned into
phCMV1 (Genlantis, USA), pCAGGS (Niwa et al., 1991), and
their derivatives.
For polycistronic expression, concatenation of CDSs was
carried out (Supplementary Figure S1). Briefly, the CDS of
each RdRp subunit was amplified as three types of cDNA for
the most upstream, internal, and most downstream positions
of an open reading frame (ORF) (Supplementary Figure
S1A, designated as α, β, and γ fragments, respectively).
The ends of each fragment were modified using specific
oligonucleotides (Supplementary Table S2, P1–P15). A unique
Xho I site followed by a Kozak sequence (Kz) was added
to the upstream end of the α fragment. The authentic stop
codons at the downstream ends of α and β fragments were
replaced by the TaV2A peptide CDSs (Supplementary Figure
S1D, TaV2A1, TaV2A2, and TaV2A3 for PB1, PB2, and
PA fragments, respectively) with X-TaV2An-GRGSct-rev and
TaV2An-g/aGRGS-rev primers. The original TaV2A nucleotide
sequences were derived from pDON-5 OKSLN (Takara Bio,
Japan) and the TaV2A1, TaV2A2, and TaV2A3 nucleotide
sequences contained synonymous substitutions (Supplementary
Figure S1D) to prevent homologous recombination in host
cells. The β and γ fragments lacked the start codon (ATG)
using an X-wo1Met-for primer (Figure 1A). The γ fragments
FIGURE 1 | Schematic representations of polycistronic RdRp
expression vectors. (A) Concatenation of CDSs of RdRp subunits with
TaV2A self-processing sequence. The bicistronic PB1-PA ORF is shown as an
example. The stop codon (∗) of the upstream CDS was removed and GS
linker-TaV2A peptide CDS was added to the end. Since TaV2A peptide was
separated at the Gly-Pro present at the end of the peptide (an arrowhead with
a line), the downstream subunit has an additional proline residue at the
N-terminal end. Consequently, the original first ATG/methionine codon of the
downstream CDS was replaced by proline (M1P substitution, indicated as
“Pro” in the PA CDS). (B) CDS order of bi-, tri-, and tetra-cistronic ORFs. PB2,
PB1, PA, and the hygromycin B phosphotransferase CDSs (abbreviated as 2,
1, a, and HygR, respectively) were concatenated in-frame with TaV2A peptide
(2A) and/or One-STrEP/Twin-strep affinity tag (OS) CDSs (Schmidt et al.,
2013). The start and end of each ORF are indicated by open (first ATG) and
closed (stop) triangles, respectively. TaV2A peptide-derived proline
codons/residues are indicated with “Pro” at the beginning of each
downstream CDS. The names (left side) and lengths of ORFs (right side) are
indicated. (C) Plasmid map of phCMV1-f1Kpn, a derivative of phCMV1.
Additional Kpn I site (indicated as ∗Kpn I) was created in the f1 ori region. The
ORFs exemplified in (B) were inserted between unique Xho I and Not I sites of
phCMV1 or phCMV1-f1Kpn and were transcribed to mRNA under the control
of CMV promoter (pCMV). The original phCMV1 vector was routinely used for
protein expression. The phCMV1-f1Kpn vector was for establishing stable cell
lines expressing RdRp.
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contained a unique Not I site at the downstream end derived
from the X-STP-NotI-rev primer. For bicistronic expression,
the α-fragments of the PB2, PB1, and PA CDSs were ligated
with the γ-fragments for the three CDSs, producing the α–γ
fragments in six combinations (Supplementary Figure S1B).
The α–γ fragments were amplified with a pair of the most
upstream and downstream primers, XhoI-Kz-X-for and X-STP-
NotI-rev primers, and were cloned into phCMV1 (referred
to as phCMV-mod2P-αγ). For tricistronic expression, the α–β
and β–γ fragments were made (Supplementary Figure S1B)
and overlap PCR was carried out by using the fragments as
templates and a pair of most upstream and downstream primers
(Supplementary Figure S1C). The resultant αβγ PCR products
were similarly cloned into phCMV1 (referred to as phCMV-
mod3P-αβγ).
For affinity purification, the Twin-Strep tag (formerly known
as the One-STrEP tag, IBA, Germany) sequence (Schmidt et al.,
2013) was inserted at the downstream end of the PB2 CDS
in-frame with relevant primers (Supplementary Table S2, P16–
P18), and the product was referred to as phCMV-mod3P-1a2os.
For stable cells expressing the RdRp subunits, the HygR CDS
was placed at the most downstream of the monocistronic and
polycistronic ORFs in phCMV1-f1Kpn, a phCMV1 derivative
containing an additional Kpn I site in the f1 ori (Figure 1C) by the
In-Fusion cloning system using relevant primers (Supplementary
Table S2, P19–P36). The resultant plasmids were referred to as
phCMV-X-HygR.
Escherichia coli Mach1 or DH10B strain (Life Technologies,
USA) was routinely used for transformation with expression
vectors. In the case of RdRp subunit expression vectors, an E. coli
Mach1 or HB101 strain was used and cultured at 30◦C for
24–36 h because of temperature-sensitive growth, as described in
the Section Discussion.
DNA Transfection and Western Blotting
Analysis
Equimolar plasmid vectors, pCAGGS (for NP expression),
phCMV (for RdRp subunits expression), and pPolI (for cRNA
expression), were mixed and were transfected to HEK293T or
MDCK cells. Briefly, total N µg DNA and 2.5 × N µl of
Lipofectamine 2000 (Life Technologies) were separately diluted
in 25 × N µl of Opti-MEM I (Life Technologies) and were
incubated for 5 min. These solutions were mixed and incubated
for 30 min. The mixtures were inoculated to 5 × 105 cells. In
some experiments, MG132 (Calbiochem, USA) was added at
20 µM. At 24 h post-transfection (hpt), cells were harvested for
Western blotting analysis and mini-genome assay. For stable cell
lines, the medium was replaced with selective medium including
the neomycin analog (G418) or hygromycin B (HygB) (Nacalai
Tesque, Japan).
For Western blotting, protein samples were separated by
SDS-PAGE (7.5% gel), transferred to PVDF membrane, and
probed with rabbit anti-PB2, -PB1, -PA antisera, and anti-NP
polyclonal antibody. Chemiluminescence detection was carried
out by using the ECL or ECL Prime reagent (GE healthcare, UK).
Polycistronically expressed proteins harboring processed-TaV2A
peptide were detected with rabbit anti-TaV2Apep polyclonal
antibody.
Mini-Genome Assay
HEK293T cells were cotransfected with the reporter cRNA
expression vector and various combinations of RdRp and NP
expression vectors. At 24 hpt, cells were harvested and luciferase
activity was measured in relative light units (RLUs) by using
ONE-Glo Luciferase Assay System (Promega, USA). The RLU
of each sample was indicated as folds relative to the RLU of
control sample using three monocistronic expression vectors for
RdRp.
Establishment of Stable Cells and Cell
Lines Expressing RdRp
Following transfection, MDCK cells were cultured for 2 weeks
with occasional passages in the presence of 800 µg/ml of G418
or 400 µg/ml of HygB. For stable cell lines expressing RdRp,
cell cloning was carried out by limiting dilution in the presence
of HygB. TaV2A peptide-positive clones were isolated after
indirect immunofluorescence microscopy with anti-TaV2Apep
antibody. In each cell clone, fluorescent images for RdRp were
acquired by conventional fluorescence microscope (BZ-8000,
KEYENCE, Japan) and the expression levels of approximately 50
cells were semiquantified by using ImageJ software (Schneider
et al., 2012). The clone No. 5, with the highest level of RdRp
expression, was used for observation of cell shapes and cell
cycle analyses by Cell-Clock assay (Biocolor, UK) and flow
cytometry.
Flow Cytometric Analysis
Madin-Darby canine kidney cells were detached with trypsin-
EDTA and washed with PBS. Cells were fixed with 4%
paraformaldehyde and were immunostained with rabbit anti-
TaV2Apep antibody and Alexa Fluor 488-conjugated anti-rabbit
Ig secondary antibody (Life Technologies). For cell cycle analysis,
cells were fixed with chilled 70% ethanol over 4 h. After
rehydration with PBS containing 1% BSA, immunofluorescent
staining was similarly carried out. Cells were treated with
100 µg/ml RNase A at 37◦C for 30 min and stained with
25 µg/ml propidium iodide (PI, Nacalai Tesque). By flow
cytometer (FC 500, Beckman Coulter, USA), forward- and side-
scatters with linear amplification (FS- and SS-Lin, respectively),
fluorescence intensity of Alexa Fluor 488 with logarithmic
amplification (FL1-Log) were collected. For cell cycle analysis,
fluorescence intensity of the PI with linear amplification (FL3-
Lin) and its peak value (AUX) were also collected. Signal analyses
were carried out by using CXP software (Beckman Coulter)
or Flowing Software version 2.5.1 (www.flowingsoftware.com).
TaV2A peptide-positive events were separated from 1∼2 × 104
total events on a dot plot of FS-Lin versus FL1-Log. For cell
cycle analysis, singlet events were chosen from 1 × 105 total
events on a dot plot of FL3-Lin versus AUX. G0/G1, S, and G2/M
regions on a FL3-Lin histogram were automatically separated by
using a region control tool of Flowing Software for cell cycle
analysis.
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Reconstitution and Isolation of vRNP
HEK293T cells (5 × 106 cells) were cotransfected with
phCMV-mod3P-1a2 or -1a2os (polycistronic 1a2 or 1a2os ORF
expression vector), pCAGGS-modPR8-NP, and pPolI-modPR8-
C6. At 24 hpt, cells were washed with cold PBS and were lysed
with 1 ml of NET buffer (20 mM Tris-HCl (pH 7.9), 0.5 M
NaCl, and 1 mM EDTA) containing 0.5% Nonidet P-40 (NETN)
supplemented with 1 mM DTT, and protease inhibitor cocktail
(Cat. No. 25955-11, Nacalai Tesque). After centrifugation at
17,400×g for 5 min, the supernatant (input lysate) was used
for affinity pull-down assay. Ten microliter packed volume of
MagStrep type 2HC beads (IBA) was incubated with 500 µl of
NETN containing 40 or 400 µl of input lysate, 1 mM DTT,
100 ng/µl of BSA, and protease inhibitor cocktail, for 60 min at
4◦C by using an orbital rotator and was washed with NETT (NET
buffer containing 0.5% Tween-20) for 5 min twice. The beads
were divided into aliquots for SDS-PAGE followed by Western
blotting and for qPCR for viral RNAs, as reported previously
(Momose et al., 2011).
RESULTS
Construction of Polycistronic RdRp
Expression Vectors
To construct polycistronic ORFs, the first methionine and stop
codons of each CDS for RdRp subunits were removed and the
three CDSs were joined in-frame with di-peptide linker (GS)
followed by a TaV2A peptide (EGRGSLLTCGDVEENPGP) CDSs
in six different subunit CDS orders (Figure 1 and Supplementary
Figure S1). Resultant subunits expressed from the most upstream
and the internal CDSs harbored additional 19 residues of GS
linker and processed form of TaV2A peptide at the C-terminal
ends, and the first methionine codons of subunits expressed from
the internal and the most downstream CDSs were substituted
by proline derived from the last residue of TaV2A peptide
(M1P substitution) (Figure 1A). We used phCMV-1 (Genlantis),
a small mammalian expression vector (Figure 1C). phCMV1-
f1Kpn, a phCMV-1 derivative in which an additional Kpn I site
was created in the f1 ori region, was also used to linearize the
vector. The polycistronic ORFs were inserted between the unique
Xho I and Not I sites of the expression vectors (12 kbp maximum).
In the same manner, bicistronic, and monocistronic vectors were
also created.
Reconstitution of Functional RdRp and
vRNP
To estimate the reconstitution efficiency of functional RdRp,
we employed a mini-genome assay. HEK293T cells were
cotransfected with various combinations of polycistronic and
monocistronic expression vectors for RdRp (Figure 2A, left
side) plus the NP and the model genome expression vectors
(right side). In our mini-genome assay, the model viral RNA
is transcribed as a positive-strand cRNA under the control
of an RNA polymerase I promoter (Figure 2A). Primer-
independent negative-strand RNA synthesis (cRNA to vRNA
FIGURE 2 | Reconstitution of functional vRNP by various
combinations of the RdRp expression vectors. (A) Schematic
representation of structures of expression vectors for a mini-genome
assay. In HEK293T cells, three subunits of RdRp are transiently expressed
from (i) three individual monocistronic vectors, (ii) a combination of one
bicistronic and one monocistronic vectors, or (iii) a tricistronic expression
vector. In polycistronic expression, processed TaV2A peptide at the
C-terminal ends of the most upstream and internal CDS products are
depicted as rectangles protruded from circles, and the proline residues at
the N-terminal ends of the internal and most downstream CDS products
are indicated as “Pro”. RdRp and NP are expressed under the control of
RNA polymerase II promoters (pII, red lines). A positive-strand cRNA is
transcribed under the control of an RNA polymerase I promoter (pI, blue
line). The reporter cRNA contains the firefly luciferase CDS (Luc) flanked
by untranslated regions of influenza A virus NS segment in positive sense.
(B–E) Representative Western blots (B,D) and mini-genome assays (C,E)
in combinations of bicistronic and monocistronic vectors (B,C) and
tricistronic RdRp expression vectors (D,E). Lanes in (B,D) correspond to
columns in (C,E), respectively. Viral proteins were detected with rabbit
anti-PB2, -PB1, and -PA antisera and anti-NP antibody (B,D). Reporter
luciferase activities were measured in RLU and the average with standard
deviation from four independent experiments are shown as folds. The RLU
of control sample (3 × monocistronic) was set at 1.0 in each experiment.
replication) occurs by the reconstituted RdRp, resulting in the
formation of the vRNP complex. This reconstituted vRNP is
used for the primer-dependent mRNA synthesis catalyzed by the
RdRp (vRNA to mRNA transcription), leading to expression of
luciferase as a reporter. The reconstituted vRNP is also used for
the next step of replication, primer-independent positive-strand
RNA synthesis (vRNA to cRNA replication). The use of cRNA as
an initial RNA assures that the reconstituted RdRp is functional
and has both replication and transcription activities.
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The expression of RdRp subunits and NP was detected
by Western blotting (Figures 2B,D). The reconstitution of
functional RdRp/vRNP complex was assessed by luciferase
activity (Figures 2C,E). The expression levels of RdRp subunits,
especially PB2 and PA, from polycistronic expression vectors
were low, as compared with those expressed from monocistronic
vectors (Figures 2B,D, compare lanes two and 3–8). It is likely
that the translation resume at the TaV2A sequence of the
polycistronic mRNA was inefficient and/or that the protein with
the TaV2A-derived residues was unstable.
Mini-genome assays (Figures 2C,E) showed that the luciferase
activities were detected only in the presence of all three
RdRp subunits (columns 2–8) but that the levels varied,
depending on the combination of vectors and the subunit CDS
orders. In tricistronic ORF expression, PB1 was clearly detected
even though the protein levels were slightly lower than that
produced by monocistronic PB1 expression, whereas the levels
of tricistronically expressed PB2 and PA were very low or below
the detection limit (Figure 2D). Mini-genome assays, however,
revealed that the luciferase activities were not similar levels in the
tricistronic ORF vectors (Figure 2E). The luciferase expression
by the PB1-PA-PB2 and PB1-PB2-PA (referred to as 1a2 and
12a) ORF vectors markedly increased up to four to fivefolds
(Figure 2E, columns 3 and 4). The luciferase expression by the
a12 and a21 ORF vectors (columns 7 and 8) was equivalent to that
of the control sample and that by the 21a and 2a1 ORF vectors was
not detected (columns 5 and 6). These results indicated that the
quantity of functional RdRp complex reconstituted in cells did
not correlate with the protein levels of RdRp subunits expressed
in the cells.
More importantly, these observations suggest that the
reconstitution efficiency of functional RdRp complex is greatly
influenced by the most upstream CDS of a tricistronic ORF.
This trend was also observed in combinations of bicistronic
and monocistronic vectors. A comparison of the 12 and 21
ORF vectors (Figure 2B, 12+PA and 21+PA) indicated that
PB1 CDS at the upstream resulted in the increase of reporter
expression by threefold (Figure 2C, compare columns 3 and 5).
A similar increase was observed for the 1a and a1 ORF vectors
(Figures 2B,C, columns 4 and 7). Taken together, these results
suggest that the PB1 CDS at the most upstream of polycistronic
ORF is preferable for efficient reconstitution of functional RdRp.
Both PA and PB2 CDSs were tolerant at the most downstream
in tricistronic ORFs (Figure 2E, compare columns 3 and 4),
suggesting that addition of the 19 residues of the linker and
processed TaV2A sequence to the C-terminal end of PB2 or PA
does not prevent reconstitution of functional RdRp.
Proteasomal Degradation of the PA
Protein Expressed from the Downstream
of TaV2A Sequence
Tricistronic RdRp expression systems allowed for efficient
reconstitution of functional RdRp with three subunits. Although
the levels of PB2 and PA were sufficient for catalytic assays
such as a mini-genome assay, they appeared insufficient for
purification of reconstituted vRNP as protein sources such as
structural studies. To improve the yield of functional RdRp,
we tested the following three methods: One was a mutagenic
approach by which the expression of the downstream protein was
expected to be improved to the stoichiometric amounts. Another
was the establishment of stable cell lines expressing RdRp to
ensure the RdRp expression in all cells without transfection. The
other was increasing the scale of cell culture followed by affinity
purification.
First, using the bicistronic 1a ORF vector (Figure 1A), we
introduced amino acid deletions or substitutions into the TaV2A
sequence and explored whether the inefficient downstream
translation was rescued by the mutations (Supplementary
Figure S2). However, none of the mutants we tested showed
any improvement of the downstream PA expression. It has
been known that the type of residues (e.g., F, W, Y, L, I,
R, K, and H) at the N-terminal end significantly reduce the
protein half-life (Varshavsky, 1997). In the 1a ORF construct,
the downstream PA expressed from this bicistronic vector
contained a M1P substitution (Figure 1A). We speculated that
this unique mutation decreased PA protein half-life. In fact, the
downstream PA was stabilized in the presence of a proteasome
inhibitor MG132 (Lee and Goldberg, 1998) (Figure 3B, lane 6;
Supplementary Figure S3, lane 4), indicating that the apparently
decreased expression of the downstream PA was likely due to the
M1P substitution but not to inefficient translation resume at the
TaV2A sequence. Then, we modified the N-terminal end of the
downstream PA. Because the first proline cannot be changed in
the 2A/2A-like sequence self-processing system, we substituted
the second glutamate (E2X) which possibly affected the protein
half-life. However, none of E2X mutants we tested showed any
improvement of protein stability (Supplementary Figure S3). The
only case showing stabilization of the downstream PA was that
the original first methionine was restored between N-terminal
end proline and the second glutamate, i.e., 1a(Met) ORF vector
(Figure 3B, lane 9), resulting in one proline extension to the
N-terminal end of wild-type PA sequence (Figure 3A).
Thus, the protein stability was improved by using the 1a(Met)
mutation or a proteasome inhibitor. However, the reconstitution
efficiency of functional RdRp did not correlate with the stability
of the downstream PA. When we reconstituted RdRp using
the bicistronic 1a(Met) ORF vector with the monocistronic
PB2 vector, the luciferase activity became lower than that
by the original 1a ORF and the monocistronic PB2 vectors
(Figure 3C, compare columns 5 and 9). This result suggests
that only one addition of proline at the N-terminal end of PA
resulted in a significant decrease of the reconstitution efficiency
of functional RdRp. We found that treatment with MG132
abolished the luciferase expression (Figure 3C, even number
columns), consistent with a previous study in which RNA
synthesis of influenza virus was inhibited in the presence of
MG132 (Widjaja et al., 2010).
Establishment of Stable Cell Lines with
Polycistronic Expression Vector
Next, we attempted to establish stable cell lines expressing
RdRp. Cotransfection of the monocistronic expression vectors
for each subunit requires selection of cell clones by three
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FIGURE 3 | Stabilization of the downstream PA expressed from the
1a ORF by amino-terminal mutation or treatment with proteasomal
inhibitor MG132. (A) Representation of the bicistronic 1a ORF vector
with mutations at the TaV2A and PA N-terminal sequences. The
processing site of TaV2A peptide is indicated as an arrowhead. Amino
acid substitutions C9A and E14S in TaV2A peptide, E2X or E2M in PA,
and insertions M in PA are indicated in red. E2X indicates substitution of
the second glutamate residue of the downstream PA. N-terminal
sequences of each RdRp subunit are shown at the top. (B) Western
blotting analysis of the downstream PA expression. HEK293T cells were
transfected with monocistronic vectors (lanes 1–4), the bicistronic 1a ORF
vector (lanes 5 and 6), and its derivatives (lanes 7–12) and were
incubated in the absence or presence of 20 µM MG132. PB1 and PA
were detected using rabbit anti-PB1 and anti-PA antisera, respectively.
(C) Mini-genome assays using monocistronic and bicistronic RdRp
expression vectors in various combinations. RdRp expression vectors were
cotransfected with NP and reporter cRNA expression vectors to HEK293T
cells. After 24-h incubation in the absence or presence of MG132,
luciferase activities were measured. The fold increase of RLU is shown as
average with standard deviation in three independent experiments. The
RLU of control sample (lane 3, PB2+PB1+PA) was set at 1.0 in each
experiment.
different resistant markers to ensure expression of the three
subunits otherwise by RdRp activity-based screening. In
contrast, the use of polycistronic expression vector with a
single selection marker was expected to allow for expression
of all the three subunits in individual cells, leading to
the efficient reconstitution of functional RdRp. Furthermore,
it is often experienced that when a target gene and a
drug resistance gene are coexpressed from different loci,
the expression of the target gene is suppressed despite
acquisition of the drug resistance. Thus, we added the
HygR CDS to the downstream of the polycistronic and
monocistronic ORFs (Figure 1B). The acquisition of HygB
resistance by HygR ensures the expression of the upstream
RdRp CDSs.
Madin-Darby canine kidney cells were transfected with the
polycistronic vectors. First, we screened in the presence of
G418 for the neomycin resistance gene, which was expressed
from the locus other than the polycistronic ORFs (Figure 1C).
When the drug-resistant cell populations were obtained
and analyzed by indirect immunofluorescence microscopy
using anti-TaV2Apep antibody, the frequency of TaV2A
peptide-positive cells was low (Figure 4A, G418). Flow
cytometry revealed that the percentage of AcGFP-expressing
cells was 53.0% and that of cells expressing NP, one of vRNP
components, was 32.4% (compare with Figure 4B). However,
the percentages of cells expressing the RdRp subunit(s)
were extremely low (maximum 1.2% in the a2-HygR ORF
case).
Then, we carried out cell selection with HygB. As shown in
Figure 4A (HygB), the percentages of AcGFP- and NP-positive
cells markedly increased to 98.1 and 97.4%, respectively. The
percentages of cells expressing the RdRp subunits also increased
to 11.6–69.3% when compared with the rate by G418 selection.
Among these RdRp cases, there was a trend that the positive
rate was relatively high when the ORF contained the PA CDS
(1aHygR, a2HygR, and PAHygR).
Next, we carried out cloning of the stable cell lines. We
constructed 1a2HygR ORF derivatives in which the One-
STrEP/Twin-Strep tag CDS (os) (Schmidt et al., 2013) was
inserted between the PB2 CDS and the HygR CDS to allow
affinity purification (Figure 1B). The 1a2osHygR ORF vector was
linearized with Kpn I at the f1 ori region and was transfected to
the MDCK cells. The HygB-resistant cell population was selected
and was subjected to limiting dilution cloning to establish
stable cell lines expressing RdRp (Supplementary Figure S4).
Despite cell cloning, the expression level of RdRp in each
cell varied, ranging from strongly positive [mean fluorescence
intensities (MFI) >200] to below the visual detection limit
(MFI <100). Clone No. 5 was composed of cells with relatively
high level of expression. After several additional passages, we
measured again the RdRp expression level by flow cytometer
(Figure 4C). The positive rate of 1a2osHygR clone No. 5
was slightly higher (18.5%) than that of the heterogenous
1a2HygR cell population (11.6%). It is possible that the
polycistronic RdRp-HygR expression tends to be quickly silenced
to a minimum expression level required to maintain drug
resistance.
Since the growth of HygB-resistant cells expressing all
RdRp subunits was extremely slow, we explored the possibility
of cell cycle arrest by using Cell-Clock Assay (Biocolor), a
colorimetric detection of the cell cycle phase (Supplementary
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FIGURE 4 | Improvement of the RdRp-positive cell ratio by polycistronic expression of a selection marker from the most downstream of ORF.
(A) Measurement of the RdRp-positive cell ratios. MDCK cells were transfected with unlinearized phCMVK-X-HygR polycistronic expression vectors (X is indicated
above a column). Following drug selection in the presence of G418 or HygB (upper and lower panels, respectively) for 2-weeks, indirect immunofluorescence
microscopy (top images) and flow cytometry (middle plots and bottom histograms) were carried out using anti-TaV2Apep antibody (FL1, shown in red). In fluorescent
images, nuclear DNA and AcGFP were also shown in blue and green, respectively. Axes of flow cytometric plots were indicated in (B) and the parameters were
described in the Materials and Methods section. Middle dot plots, cell size (FS Lin) versus TaV2A peptide content (FL1 Log) with a polygon gate and the ratio of
TaV2A peptide-positive cells (red). Bottom histograms, the TaV2A-peptide content (FL1 Log) versus cell counts (events), in which TaV2A peptide-positive events (red)
are superimposed on the total events (gray). (B) Flow cytometric analyses of untransfected MDCK cells (negative control). (C) MDCK cells were transfected with
linearized phCMVK-1a2osHygR and TaV2A peptide-positive clones were isolated by limiting dilution in the presence of HygB (Supplementary Figure S4). After
several passages, the clone No. 5 was analyzed by flow cytometer.
Figure S5A) and by measuring DNA content by flow cytometry
(Supplementary Figures S5B,C). Although results did not show
the cell cycle arrest in the RdRp expressing cells, this cell line
displayed aberrant cell morphology such as cell enlargement
(Supplementary Figure S5A, left side), confirming high forward
scatter in flow cytometry (Supplementary Figure S5B, FS Lin vs
FL1 Log of RdRp).
Isolation of Reconstituted vRNP Complex
We used a large volume of the cell lysates, in which
RdRp was polycistronically expressed, and attempted to isolate
the reconstituted single segment vRNP. To this end, single
polycistronic expression vector (1a2 or 1a2os ORF) or three
monocistronic vectors (PB2os, PB1, and PA) for the RdRp
subunits were cotransfected with the NP and cRNA expression
vectors into HEK293T cells. The cell lysates were subjected to
streptavidin-based affinity pull-down assay. The viral proteins
(PB2, PB1, PA, and NP) and vRNA were eluted from the affinity
beads and were analyzed by Western blotting and polarity-
specific qPCR, respectively. In this polycistronic expression
system, we used cRNA as an initial RNA transcribed from
the RNA expression vector (Figure 2A), thereby ensuring the
polarity-specific vRNA quantification.
When equal volumes of lysates were used for this affinity
pull-down, the level of PB2os extracted from the polycistronic
RdRp expression sample was about 10-fold lower than that
of the monocistronic expression sample (Figure 5A, anti-PB2,
compare lanes 4 and 5). Since our polycistronic expression
system did not produce high levels of PA and PB2os, we
used large volumes of the cell lysates and compared the
coprecipitation efficiencies of vRNA and NP per RdRp with
the efficiency obtained by monocistronic expression system.
When 10-fold excess volumes of the polycistronically expressed
cell lysates were used for affinity pull-down, the level of
extracted PB2os was comparable to that obtained from the
monocistronically expressed cell lysates (Figure 5A, anti-
PB2, compare lanes 4 and 7). In this condition, the levels
of coprecipitated PB1 and PA, were also comparable (anti-
PB1/PA, lanes 4 and 7). From these results, the levels of
precipitated RdRp were considered as nearly equivalent. A careful
observation indicated, however, that only a trace of NP was
coprecipitated in the monocistronic expression system (anti-NP,
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FIGURE 5 | Affinity pull-down assay of reconstituted vRNP. (A) Western
blotting analyses of input lysates (lanes 1–3) and eluates from affinity beads
(lanes 4–8) using rabbit anti-PB2, -PB1, -PA antisera, anti-TaV2Apep, and -NP
antibodies. vRNP components were expressed and reconstituted by
cotransfection of the RdRp expression vectors (poly, phCMV-mod3P-1a2 or
-1a2os; mono, phCMV-modPR8-PB2os, -PB1, and -PA) with NP and
segment 6 cRNA expression vectors (pCAGGS-modPR8-NP and
pPolI-modPR8-C6, respectively) in the HEK293T cells. The relative volume of
input lysate used in each lane was shown. The 1a2 ORF vector, not
containing affinity tag, was used as a negative control (indicated as minus).
Blots are derived from a single pull-down experiment and are representative of
three independent experiments. (B) Quantitation of coprecipitated vRNA.
Each column corresponds to the same lane as shown in (A). Polarity-specific
reverse transcription was carried out using the modified segment 6-specific
primer for vRNA (Supplementary Table S1). Semiquantitative real-time PCR
was carried out by using the modified segment 6-specific primer set with
standard DNA, pBSmodPR8qPCRSTD. The fold increase of coprecipitated
vRNA is shown as average with standard deviation in three independent
experiments. The vRNA level of monocistronic expression sample (lane 4) was
set at 1.0.
lane 4). The RdRp consists of equimolar PB2, PB1, and
PA subunits and the vRNP complex contains one set of
RdRp, one copy of viral RNA and excess molar of NP. It is
possible that the RdRp complex but not the vRNP complex
was preferentially formed in the monocistronic expression
system.
Consistent with these findings, the coprecipitated vRNA
levels in the polycistronic expression was fivefold higher than
that observed in the monocistronic expression when similar
levels of RdRp were isolated (Figure 5B, compare columns
4 and 7), indicating that vRNA formed vRNP complex
more efficiently when RdRp complex was reconstituted by
polycistronic expression. From these results, we concluded
that, though 10-fold volume of cell lysate was required to
obtain an equal quantity of RdRp, the polycistronic RdRp
expression system allowed for the reconstitution of vRNP
complex and for the isolation of the complex by one-
step affinity purification. Thus, our self-processing 2A-based
polycistronic expression may be good for biological analysis
requiring enzymatically functional RdRp expression, such as a
mini-genome assay and a reverse genetic approach, but not
suitable for analysis requiring a large quantity of reconstituted
vRNP.
DISCUSSION
Our present study displayed the reconstitution of functional
RdRp by the polycistronic expression of three RdRp subunits
with TaV2A self-processing sequence. This expression system
allowed us to obtain reconstituted vRNP with less purification
steps and also to establish stable cell lines expressing RdRp,
a viral multi-subunit complex. We suggest that the efficient
reconstitution of RdRp and vRNP may allow more detailed
functional analyses such as the residues of RdRp necessary
for viral transcription and RNA genome replication for full
understanding of the influenza virus multiplication. A higher
specific activity of vRNP (Figure 2) achieved by an efficient
reconstitution (Figure 5), may allow us to increase the sensitivity
of drug screenings such as mini-genome assays. The use of the
stable cell lines expressing RdRp will make cell-based antiviral
screens possible. It is also possible to screen the host factors
necessary for functional RdRp/vRNP formation and viral RNA
synthesis. Here we discuss the pros and cons of the polycistronic
expression system.
Advantages of the Polycistronic
Expression by Using a 2A/2A-Like
Self-processing Sequence
A variety of expression systems for the influenza virus RdRp
and vRNP complexes have been reported, and each system has
both advantages and disadvantages. If a large quantity of RdRp
is required for studies, such as a crystal structure analysis, the
expression systems using insect viruses are advantageous (Reich
et al., 2014; Hengrung et al., 2015). The use of Drosophila
or yeast cells allows us to find host cell factors involved
in viral RNA synthesis by virtue of their genetic knowledge
(Naito et al., 2007a; Hao et al., 2008). However, it is uncertain
whether the RdRp/vRNP complex reconstituted in these cells are
functionally identical with that reconstituted in a mammalian
cells. In contrast, MDCK and HEK293T cells are infection-
permissive and have commonly been used to reconstitute these
multi-subunit complexes by cotransfection of monocistronic
expression vectors. However, as shown in this study, the
reconstitution efficiency of functional RdRp/vRNP complex was
considerably low because the ratio of RdRp subunits varies in
each cell.
One advantage of self-processing 2A-based polycistronic
expression is to ensure coexpression of multiple proteins in
a single cell, suggesting potential applications requiring the
biological quality, i.e., the uniformity and reproducibility of the
expression ratio, rather than the quantity. By this approach,
we explored the reconstitution of functional RdRp complex
and vRNP complex with a TaV2A-based polycistronic RdRp
expression vector. The reconstitution efficiency of RdRp in
the polycistronic expression system was higher than that in
the monocistronic expression system (Figure 2). If the activity
of RdRp was estimated only from protein expression levels
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in Figure 2D, it would be expected that the monocistronic
expression sample (lane 2) harbors much higher reporter
activity than the others. However, we found that it was not
the case. Even though PB2 and PA levels were below the
detection limit, polycistronically expressed RdRp from the
12a and 1a2 ORF vectors showed much higher activities
(Figure 2E, lanes 3 and 4). This result implies that most
of the monocistronically expressed proteins probably exist
as incomplete/non-functional complexes or monomers and
that the contamination of such defective complex make it
difficult to purify the target complex. The improvement
of the RdRp reconstitution efficiency allowed us to isolate
reconstituted vRNP from a crude cell lysate with lesser
purification steps (Figure 5). In our polycistronic expression,
the levels of PB2 and PA were still low, as compared with
those observed in the monocistronic expression, but the
reconstitution of vRNP was considerably efficient. We suggest
that if the polycistronic expression of downstream PB2 and PA
could be stabilized, the reconstitution efficiency would more
increase.
Internal ribosomal entry site (IRES) has been also used for
multiple protein expression from one mRNA/vector (Jang et al.,
1988; Pelletier and Sonenberg, 1988; Thompson, 2012). However,
we believe that the polycistronic expression based on the 2A
self-processing has some advantages, as compared with the IRES
expression system. A minimum nucleotide length of IRES is 10-
fold longer than that of the 2A sequence (about 550–600 nt
and 60 nt, respectively) and this fact allows to minimize the
size of multiple protein expression vector. Another advantage
is translation mechanisms for multiple protein expression. IRES
is based on the re-entry of ribosomal complex onto an mRNA,
whereas the self-processing of 2A/2A-like sequence is thought
to progress without dissociation or re-entry of ribosome for
downstream translation (Donnelly et al., 2001b). This serial
translation of self-processing 2A/2A-like sequence would better
equalize the translation rates of upstream and downstream
CDSs.
Another advantage of the polycistronic expression system
is the saving of cellular transcription- and translation-related
factors required for expression of multiple proteins. For
example, when RdRp and NP were coexpressed from the
equimolar ratio of four monocistronic expression vectors, the
level of NP expression was markedly reduced, possibly due
to the shortage of cellular RNA polymerase II-related factors
(Figure 2D, lane 2). The use of a polycistronic vector could
halve the kind of protein expression vectors and eliminate
the shortage of cellular transcription- and translation-related
factors for their expression (Figure 2D, lanes 3–8). Therefore,
if a large quantity of multi-subunit complexes is wanted as
materials for some experiments, it is better to express the
subunits polycistronically, but the molar difference of proteins
in such a complex should be taken into account, as we
expressed the RdRp subunits and NP from different vectors
(Figure 2A).
The other beneficial use of the self-processing 2A-based
expression system is to ensure expression of all the upstream
CDSs when a drug-resistant gene is placed at the most
downstream in a polycistronic ORF (e.g., Figure 1B, 1a2osHygR
ORF). The selection of drug-resistant cells allows us to
establish stable cells expressing all the genes we want. The
longer an ORF becomes by connecting multiple CDSs, the
more frequently a disruption of the ORF occurs, especially
when the polycistronic expression vector plasmid integrates
into the host genome. If a drug-resistant gene is present
at the most downstream in the polycistronic ORF, one
can select the cells surely expressing all the upstream
genes in the presence of the drug. But if such a selective
marker is located in another locus and the ORF of interest
destroyed or silenced, one cannot eliminate such cells by drug
resistance screening. By this approach, we obtained stable
cells, almost all of which expressed fluorescent proteins and
NP, without cell cloning (Figure 4A, HygB, AcGFP- and
NP-HygR).
Drawbacks and Limitations of the
Self-processing 2A-Based Polycistronic
Expression
The major drawback of this expression system is that the TaV2A-
derived sequences remain at the ends of the polycistronically
expressed proteins. In some cases, the addition of one proline
at the N-terminal end of downstream protein and/or the
processed 2A/2A-like peptide at the C-terminal end of upstream
protein result in the loss of the protein function. If the
N- and C-terminal ends of an expressed protein need to
be kept intact, the location of the CDS is limited to the
most upstream and the most downstream of polycistronic
ORF, respectively. If both ends need to be intact, the protein
cannot be expressed polycistronically using a self-processing
2A-based vector. It has also reported that in a certain
combination of proteins (e.g., endoplasmic reticulum-targeting
protein and protein lacking any signal sequence) the CDS
order is limited in a polycistronic ORF (de Felipe and Ryan,
2004).
In this study, when the PB1 CDS was placed at the
downstream, the reconstitution of functional RdRp was
inefficient (Figure 2E), despite similar levels of PB1 expression
(Figure 2D), suggesting that not only PB1 expression level
but also its N-terminal end residues were important for
the RdRp activity. The TaV2A-derived proline residue at
the N-terminal end of downstream PB1 may have caused a
reduction in the RdRp activity. Many studies have suggested
that the PB1 N-terminal region is essential for binding to
the PA C-terminal region (Gonzalez et al., 1996; Toyoda
et al., 1996; Perez and Donis, 2001; Ghanem et al., 2007) and
structural studies have reported that the PB1 N-terminal end
is inserted into the cavity of PA C-terminal domain (He et al.,
2008; Obayashi et al., 2008). In this polycistronic expression
system, downstream protein has M1P substitution (Figure 1A),
suggesting that in our case, the first proline residue at the
N-terminal end of PB1 may have a deleterious effect on PB1-PA
binding or the overall structure of RdRp even though the
first methionine of PB1 originally penetrates the cavity and is
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exposed to solvent without forming strong interactions with PA
residues.
We also encountered the instability of the polycistronically
expressed protein. For example, the levels of polycistronically
expressed PB2 and PA were very low in many cases (Figure 2D),
whereas the levels of PB1 was comparable regardless of its CDS
location in the ORF. We found that harboring TaV2A-derived
sequences made at least PA more sensitive to the proteasomal
degradation (Figure 3B). Thus, it is necessary to consider
the CDS order and the terminal structure when proteins are
expressed in this expression system.
By using X-HygR ORF vector, we obtained stable cells
expressing the RdRp subunits, and more easily those expressing
AcGFP and NP (Figure 4A, HygB), suggesting that the number
and the kind of proteins expressed may influence to the
acquisition efficiency of stably expressing cells. We found that
when all RdRp subunits were constitutively expressed, the growth
of the host cells was impaired or inhibited. We speculated that
transcriptional repression of a polycistronic RdRp-HygR ORF
caused the loss of drug resistance. Alternatively, expression of
RdRp might be somehow stress and possibly have induced
abnormal cell morphology and cell death (Supplementary Figure
S5A), resulting in the elimination of cells expressing high levels
of RdRp.
Another technical disadvantage is that a leaky expression of
downstream proteins often occurs in E. coli cells transformed
with TaV2A-based polycistronic expression vector. In our
study, the E. coli HB101 strain, when transformed with the
polycistronic expression vector that contained PA CDS with
its start codon at the downstream of TaV2A CDS [e.g.,
bicistronic 1a(Met) ORF vector], displayed a temperature-
sensitive phenotype (Figure 6B). Constitutive expression of
target proteins in E. coli requires a prokaryotic promoter and
a ribosome binding sequence such as a Shine–Dalgarno (SD)
sequence (Shine and Dalgarno, 1974) immediately upstream
of the polycistronic ORF, neither of which is present at a
cloning site for target gene in mammalian expression vectors
(Figure 1C). In this TaV2A-based expression system, however,
continuous nine purine bases are present in the TaV2A CDS,
are possibly functioned as a SD sequence for a start codon of
downstream CDS (Romero and Garcia, 1991; Blattner et al., 1997)
(Figure 6A).
A number of viruses have self-processing 2A/2A-like
sequences (conserved sequence, DX1EX2NPGP) (Donnelly
et al., 2001a). Like porcine teschovirus and TaV, if the codon
of X2 residue is encoded by GAR (glutamate/E codons,
R = A or G), AGR (two of six arginine/R codons), AAR
(lysine/K codons), or GGR (two of four glycin/G codons),
the region is a putative SD sequence. In contrast, the foot-
and-mouth disease virus 2A self-processing sequence can
be ruled out (X2 = S). As shown in this study, the leaky
expression of target protein sometimes presents lethal or
severe temperature-sensitive phenotypes of host E. coli, and the
followings can be workarounds: culture at low temperature,
use of different host strain, elimination of a putative/original
start codon of downstream CDS (e.g., M1P substitution in
this study, Figure 1A), and/or the inactivation of a putative
FIGURE 6 | Temperature-sensitivity of Escherichia coli strains
transformed with bicistronic PB1-PA expression vectors.
(A) Representation of the TaV2A sequences of 1a, 1a(Met), and 1∗a(Met) ORF
vectors. The N-terminal sequence of PA (downstream region) and modified
TaV2A residues [1∗a(Met), upstream region] are indicated in red (uppercase
letters). A putative SD sequence is indicated in blue, and nucleotide
substitutions in the 1∗a(Met) ORF are indicated in red (lowercase letters).
(B) Colony forming assay of transformants at three different temperatures.
Mach1, DH10B, and HB101 strains of E. coli were transformed with original
phCMV-1a(Met) or -1∗a(Met) in which the putative SD sequence was
disrupted by nucleotide substitution. After recovery in SOC medium, cells
were spread on LB agar plates containing kanamycin and incubated at 25,
30, or 37◦C for 24 h.
SD sequence by nucleotide substitutions. We constructed the
1∗a(Met) ORF, in which TaV2A peptide had E14S and C9A
substitutions, to disrupt a putative SD sequence (Figure 6A,
non-conserved glutamate codon “GAA” was substituted to a
serine codon “TTC”) and improved the antigenicity against
our anti-TaV2Apep polyclonal antibody (Supplementary
Figure S2A, see anti-TaV2Apep epitope). This modification
improved the growth of transformed E. coli, especially the
Mach1 strain (the W strain derivative), at 37◦C (Figure 6B,
37◦C, compare 1a(Met) and 1∗a(Met) of E. coli Mach1
strain).
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